{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:31:16Z","timestamp":1791016276767,"version":"4.1.0"},"reference-count":56,"publisher":"American Diabetes Association","issue":"Supplement_2","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,2,1]]},"abstract":"<jats:p>Hypertension is associated with increased vascular oxidative stress; however, there is still a debate whether oxidative stress is a cause or a result of hypertension. Animal studies have generally supported the hypothesis that increased blood pressure is associated with increased oxidative stress; however, human studies have been inconsistent. Oxidative stress promotes vascular smooth muscle cell proliferation and hypertrophy and collagen deposition, leading to thickening of the vascular media and narrowing of the vascular lumen. In addition, increased oxidative stress may damage the endothelium and impair endothelium-dependent vascular relaxation and increases vascular contractile activity. All these effects on the vasculature may explain how increased oxidative stress can cause hypertension. Treatment with antioxidants has been suggested to lower oxidative stress and therefore blood pressure. However, to date, clinical studies investigating antioxidant supplements have failed to show any consistent benefit. It is noteworthy that lowering blood pressure with antihypertensive medications is associated with reduced oxidative stress. Therefore, it seems that oxygen stress is not the cause, but rather a consequence, of hypertension.<\/jats:p>","DOI":"10.2337\/dc08-s246","type":"journal-article","created":{"date-parts":[[2008,1,28]],"date-time":"2008-01-28T22:26:40Z","timestamp":1201559200000},"page":"S185-S189","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":124,"title":["Does Increased Oxidative Stress Cause Hypertension?"],"prefix":"10.2337","volume":"31","author":[{"given":"Ehud","family":"Grossman","sequence":"first","affiliation":[{"name":"From the Internal Medicine D and Hypertension Unit, The Chaim Sheba Medical Center, Tel-Hashomer, Israel, and the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031216343941400_R1","doi-asserted-by":"crossref","unstructured":"Dobrian AD, Schriver SD, Khraibi AA, Prewitt RL: Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension\u200843:48\u201356, 2004","DOI":"10.1161\/01.HYP.0000103629.01745.59"},{"key":"2022031216343941400_R2","doi-asserted-by":"crossref","unstructured":"Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y: Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone\/salt-induced hypertensive rats. Hypertension\u200843:841\u2013848, 2004","DOI":"10.1161\/01.HYP.0000118519.66430.22"},{"key":"2022031216343941400_R3","doi-asserted-by":"crossref","unstructured":"Park JB, Touyz RM, Chen X, Schiffrin EL: Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens\u200815:78\u201384, 2002","DOI":"10.1016\/S0895-7061(01)02233-6"},{"key":"2022031216343941400_R4","doi-asserted-by":"crossref","unstructured":"Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND: Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension\u200841:341\u2013346, 2003","DOI":"10.1161\/01.HYP.0000052833.20759.64"},{"key":"2022031216343941400_R5","doi-asserted-by":"crossref","unstructured":"Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, Abe Y: Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension\u200841:266\u2013273, 2003","DOI":"10.1161\/01.HYP.0000049621.85474.CF"},{"key":"2022031216343941400_R6","doi-asserted-by":"crossref","unstructured":"Tanito M, Nakamura H, Kwon YW, Teratani A, Masutani H, Shioji K, Kishimoto C, Ohira A, Horie R, Yodoi J: Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signal\u20086:89\u201397, 2004","DOI":"10.1089\/152308604771978381"},{"key":"2022031216343941400_R7","doi-asserted-by":"crossref","unstructured":"Virdis A, Neves MF, Amiri F, Viel E, Touyz RM, Schiffrin EL: Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension\u200840:504\u2013510, 2002","DOI":"10.1161\/01.HYP.0000034738.79310.06"},{"key":"2022031216343941400_R8","doi-asserted-by":"crossref","unstructured":"Bello-Klein A, Bock PM, Travacio M, Senna Sm, Llesuy S, de Bittencourt PI, Irigoyen MC, Bello AA, Kumar D, Singal PK: Myocardial oxidative stress and antioxidants in hypertension as a result of nitric oxide synthase inhibition. Cardiovasc Toxicol\u20081:43\u201350, 2001","DOI":"10.1385\/CT:1:1:43"},{"key":"2022031216343941400_R9","doi-asserted-by":"crossref","unstructured":"Fukui T, Ishizaka N, Rajagopalan S, Laursen JB Capers Q 4th, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK: p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res\u200880:45\u201351, 1997","DOI":"10.1161\/01.RES.80.1.45"},{"key":"2022031216343941400_R10","doi-asserted-by":"crossref","unstructured":"Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA: Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension\u200833:1353\u20131358, 1999","DOI":"10.1161\/01.HYP.33.6.1353"},{"key":"2022031216343941400_R11","doi-asserted-by":"crossref","unstructured":"Wu R, Millette E, Wu L, de Champlain J: Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J Hypertens\u200819:741\u2013748, 2001","DOI":"10.1097\/00004872-200104000-00011"},{"key":"2022031216343941400_R12","doi-asserted-by":"crossref","unstructured":"Ward NC, Croft KD: Hypertension and oxidative stress. Clin Exp Pharmacol Physiol\u200833:872\u2013876, 2006","DOI":"10.1111\/j.1440-1681.2006.04457.x"},{"key":"2022031216343941400_R13","doi-asserted-by":"crossref","unstructured":"Kumar KV, Das UN: Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun\u200819:59\u201366, 1993","DOI":"10.3109\/10715769309056499"},{"key":"2022031216343941400_R14","doi-asserted-by":"crossref","unstructured":"Russo C, Olivieri O, Girelli D, Guarini P, Carletto A, Corrocher R: Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens\u200816:1267\u20131271, 1998","DOI":"10.1097\/00004872-199816090-00007"},{"key":"2022031216343941400_R15","doi-asserted-by":"crossref","unstructured":"Pedro-Botet J, Covas MI, Martin S, Rubies-Prat J: Decreased endogenous antioxidant enzymatic status in essential hypertension. J Hum Hypertens\u200814:343\u2013345, 2000","DOI":"10.1038\/sj.jhh.1001034"},{"key":"2022031216343941400_R16","doi-asserted-by":"crossref","unstructured":"Lacy F, Kailasam MT, O\u2019Connor DT, Schmid-Schonbein GW, Parmer RJ: Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension\u200836:878\u2013884, 2000","DOI":"10.1161\/01.HYP.36.5.878"},{"key":"2022031216343941400_R17","doi-asserted-by":"crossref","unstructured":"Cracowski JL, Baguet JP, Ormezzano O, Bessard J, Stanke-Labesque F, Bessard G, Mallion J: Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension. Hypertension\u200841:286\u2013288, 2003","DOI":"10.1161\/01.HYP.0000050963.16405.E6"},{"key":"2022031216343941400_R18","doi-asserted-by":"crossref","unstructured":"Ward NC, Hodgson JM, Puddey IB, Mori TA, Beilin LJ, Croft KD: Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle. Free Radic Biol Med\u200836:226\u2013232, 2004","DOI":"10.1016\/j.freeradbiomed.2003.10.021"},{"key":"2022031216343941400_R19","unstructured":"Tse WY, Maxwell SR, Thomason H, Blann A, Thorpe GH, Waite M, Holder R: Antioxidant status in controlled and uncontrolled hypertension and its relationship to endothelial damage. J Hum Hypertens\u20088:843\u2013849, 1994"},{"key":"2022031216343941400_R20","doi-asserted-by":"crossref","unstructured":"Sanchez-Castillo CP, Velasquez-Monroy O, Lara-Esqueda A, Berber A, Sepulveda J, Tapia-Conyer R, James WP: Diabetes and hypertension increases in a society with abdominal obesity: results of the Mexican National Health Survey 2000. Public Health Nutr\u20088:53\u201360, 2005","DOI":"10.1079\/PHN2004659"},{"key":"2022031216343941400_R21","doi-asserted-by":"crossref","unstructured":"Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, Prabhala A, Afzal A, Garg R: The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab\u200886:355\u2013362, 2001","DOI":"10.1210\/jcem.86.1.7150"},{"key":"2022031216343941400_R22","doi-asserted-by":"crossref","unstructured":"Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R, Dandona P: Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr\u200875:767\u2013772, 2002","DOI":"10.1093\/ajcn\/75.4.767"},{"key":"2022031216343941400_R23","doi-asserted-by":"crossref","unstructured":"Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P: Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab\u200885:2970\u20132973, 2000","DOI":"10.1210\/jcem.85.8.6854"},{"key":"2022031216343941400_R24","doi-asserted-by":"crossref","unstructured":"Aljada A, Friedman J, Ghanim H, Mohanty P, Hofmeyer D, Chaudhuri A, Dandona P: Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism\u200855:1177\u20131185, 2006","DOI":"10.1016\/j.metabol.2006.04.016"},{"key":"2022031216343941400_R25","doi-asserted-by":"crossref","unstructured":"Aljada A, Ghanim H, Mohanty P, Syed T, Bandyopadhyay A, Dandona P: Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations. Am J Clin Nutr\u200880:51\u201357, 2004","DOI":"10.1093\/ajcn\/80.1.51"},{"key":"2022031216343941400_R26","doi-asserted-by":"crossref","unstructured":"Aljada A, Mohanty P, Ghanim H, Abdo T, Tripathy D, Chaudhuri A, Dandona P: Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr\u200879:682\u2013690, 2004","DOI":"10.1093\/ajcn\/79.4.682"},{"key":"2022031216343941400_R27","doi-asserted-by":"crossref","unstructured":"Dandona P, Mohanty P, Hamouda W, Ghanim H, Aljada A, Garg R, Kumar V: Inhibitory effect of a two day fast on reactive oxygen species (ROS) generation by leucocytes and plasma ortho-tyrosine and meta-tyrosine concentrations. J Clin Endocrinol Metab\u200886:2899\u20132902, 2001","DOI":"10.1210\/jcem.86.6.7745"},{"key":"2022031216343941400_R28","doi-asserted-by":"crossref","unstructured":"Dandona P, Kumar V, Aljada A, Ghanim H, Syed T, Hofmayer D, Mohanty P, Tripathy D, Garg R: Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action. J Clin Endocrinol Metab\u200888:4496\u20134501, 2003","DOI":"10.1210\/jc.2002-021836"},{"key":"2022031216343941400_R29","doi-asserted-by":"crossref","unstructured":"Khan BV, Navalkar S, Khan QA, Rahman ST, Parthasarathy S: Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease. J Am Coll Cardiol\u200838:1662\u20131667, 2001","DOI":"10.1016\/S0735-1097(01)01615-1"},{"key":"2022031216343941400_R30","doi-asserted-by":"crossref","unstructured":"McIntyre M, Bohr DF, Dominiczak AF: Endothelial function in hypertension: the role of superoxide anion. Hypertension\u200834:539\u2013545, 1999","DOI":"10.1161\/01.HYP.34.4.539"},{"key":"2022031216343941400_R31","doi-asserted-by":"crossref","unstructured":"Cracowski JL, Durand T, Bessard G: Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci\u200823:360\u2013366, 2002","DOI":"10.1016\/S0165-6147(02)02053-9"},{"key":"2022031216343941400_R32","doi-asserted-by":"crossref","unstructured":"Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL: Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension\u200836:957\u2013964, 2000","DOI":"10.1161\/01.HYP.36.6.957"},{"key":"2022031216343941400_R33","doi-asserted-by":"crossref","unstructured":"Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, Diez J: Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension\u200838:1395\u20131399, 2001","DOI":"10.1161\/hy1201.099611"},{"key":"2022031216343941400_R34","doi-asserted-by":"crossref","unstructured":"Chen X, Touyz RM, Park JB, Schiffrin EL: Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension\u200838:606\u2013611, 2001","DOI":"10.1161\/hy09t1.094005"},{"key":"2022031216343941400_R35","doi-asserted-by":"crossref","unstructured":"Schiffrin EL: Beyond blood pressure: the endothelium and atherosclerosis progression. Am J Hypertens\u200815:115S\u2013122S, 2002","DOI":"10.1016\/S0895-7061(02)03006-6"},{"key":"2022031216343941400_R36","doi-asserted-by":"crossref","unstructured":"Touyz RM: Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension\u200844:248\u2013252, 2004","DOI":"10.1161\/01.HYP.0000138070.47616.9d"},{"key":"2022031216343941400_R37","doi-asserted-by":"crossref","unstructured":"Zhang GX, Kimura S, Nishiyama A, Shokoji T, Rahman M, Abe Y: ROS during the acute phase of Ang II hypertension participates in cardiovascular MAPK activation but not vasoconstriction. Hypertension\u200843:117\u2013124, 2004","DOI":"10.1161\/01.HYP.0000105110.12667.F8"},{"key":"2022031216343941400_R38","doi-asserted-by":"crossref","unstructured":"Elmarakby AA, Loomis ED, Pollock JS, Pollock DM: NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension\u200845:283\u2013287, 2005","DOI":"10.1161\/01.HYP.0000153051.56460.6a"},{"key":"2022031216343941400_R39","doi-asserted-by":"crossref","unstructured":"Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG: Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation\u200895:588\u2013593, 1997","DOI":"10.1161\/01.CIR.95.3.588"},{"key":"2022031216343941400_R40","doi-asserted-by":"crossref","unstructured":"Schnackenberg CG, Welch WJ, Wilcox CS: Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension\u200832:59\u201364, 1998","DOI":"10.1161\/01.HYP.32.1.59"},{"key":"2022031216343941400_R41","doi-asserted-by":"crossref","unstructured":"Akpaffiong MJ, Taylor AA: Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats. Am J Hypertens\u200811:1450\u20131460, 1998","DOI":"10.1016\/S0895-7061(98)00183-6"},{"key":"2022031216343941400_R42","doi-asserted-by":"crossref","unstructured":"Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL: Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens\u200822:535\u2013542, 2004","DOI":"10.1097\/00004872-200403000-00016"},{"key":"2022031216343941400_R43","doi-asserted-by":"crossref","unstructured":"Fujii S, Zhang L, Igarashi J, Kosaka H: L-arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats. Hypertension\u200842:1014\u20131020, 2003","DOI":"10.1161\/01.HYP.0000094557.36656.D0"},{"key":"2022031216343941400_R44","doi-asserted-by":"crossref","unstructured":"Galley HF, Thornton J, Howdle PD, Walker BE, Webster NR: Combination oral antioxidant supplementation reduces blood pressure. Clin Sci (Lond)\u200892:361\u2013365, 1997","DOI":"10.1042\/cs0920361"},{"key":"2022031216343941400_R45","doi-asserted-by":"crossref","unstructured":"Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF, Vita JA: Treatment of hypertension with ascorbic acid. Lancet\u2008354:2048\u20132049, 1999","DOI":"10.1016\/S0140-6736(99)04410-4"},{"key":"2022031216343941400_R46","doi-asserted-by":"crossref","unstructured":"Fotherby MD, Williams JC, Forster LA, Craner P, Ferns GA: Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens\u200818:411\u2013415, 2000","DOI":"10.1097\/00004872-200018040-00009"},{"key":"2022031216343941400_R47","doi-asserted-by":"crossref","unstructured":"Hajjar IM, George V, Sasse EA, Kochar MS: A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am J Ther\u20089:289\u2013293, 2002","DOI":"10.1097\/00045391-200207000-00005"},{"key":"2022031216343941400_R48","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group: MRC\/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet\u2008360:23\u201333, 2002","DOI":"10.1016\/S0140-6736(02)09328-5"},{"key":"2022031216343941400_R49","doi-asserted-by":"crossref","unstructured":"Kim MK, Sasaki S, Sasazuki S, Okubo S, Hayashi M, Tsugane S: Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension\u200840:797\u2013803, 2002","DOI":"10.1161\/01.HYP.0000038339.67450.60"},{"key":"2022031216343941400_R50","doi-asserted-by":"crossref","unstructured":"Ward NC, Hodgson JM, Croft KD, Burke V, Beilin LJ, Puddey IB: The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial. J Hypertens\u200823:427\u2013434, 2005","DOI":"10.1097\/00004872-200502000-00026"},{"key":"2022031216343941400_R51","doi-asserted-by":"crossref","unstructured":"Palumbo G, Avanzini F, Alli C, Roncaglioni MC, Ronchi E, Cristofari M, Capra A, Rossi S, Nosotti L, Costantini C, Calvalera C: Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients: Collaborative Group of the Primary Prevention Project (PPP)\u2013Hypertension study. Am J Hypertens\u200813:564\u2013567, 2000","DOI":"10.1016\/S0895-7061(00)00244-2"},{"key":"2022031216343941400_R52","doi-asserted-by":"crossref","unstructured":"Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS: Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med\u2008354:1796\u20131806, 2006","DOI":"10.1056\/NEJMoa054186"},{"key":"2022031216343941400_R53","unstructured":"Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P: Vitamin E supplementation and cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med\u2008342:154\u2013160, 2000"},{"key":"2022031216343941400_R54","doi-asserted-by":"crossref","unstructured":"Saez GT, Tormos C, Giner V, Chaves J, Lozano JV, Iradi A, Redon J: Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. Am J Hypertens\u200817:809\u2013816, 2004","DOI":"10.1016\/j.amjhyper.2004.05.022"},{"key":"2022031216343941400_R55","doi-asserted-by":"crossref","unstructured":"Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, Salvetti A: Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension\u200841:1281\u20131286, 2003","DOI":"10.1161\/01.HYP.0000070956.57418.22"},{"key":"2022031216343941400_R56","doi-asserted-by":"crossref","unstructured":"Taddei S, Virdis A, Ghiadoni L, Versari D, Salvetti G, Magagna A, Salvetti A: Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension\u200841:950\u2013955, 2003","DOI":"10.1161\/01.HYP.0000063361.70525.3C"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/Supplement_2\/S185\/469266\/zdc1020800s185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/Supplement_2\/S185\/469266\/zdc1020800s185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T17:05:57Z","timestamp":1647104757000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/31\/Supplement_2\/S185\/24808\/Does-Increased-Oxidative-Stress-Cause-Hypertension"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,1]]},"references-count":56,"journal-issue":{"issue":"Supplement_2","published-print":{"date-parts":[[2008,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc08-s246","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,1]]}}}